Nonspecific interstitial pneumonia.

Abstract

Traditionally, a subset of patients diagnosed as having idiopathic pulmonary fibrosis had positive results on cellular biopsies (prominent lymphoplasmacytic inflammation), bronchoalveolar lavage lymphocytosis, a clinical response to steroids, and a better long-term prognosis. On review of the lung histopathology, the lesion was characterized by varying degrees of inflammation and fibrosis. This entity is now recognized as a distinct entity among idiopathic interstitial pneumonias.

• Authors: Brent Wayne Kinder
• Journal: Clinics in chest medicine (Clin Chest Med) Vol. 33 Issue 1 Pg. 111-21 (Mar 2012) ISSN: 1557-8216 [Electronic] United States
• PMID: 22365250 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2012 Elsevier Inc. All rights reserved.

Chemical References

• Adrenal Cortex Hormones
• Anti-Inflammatory Agents
• Immunosuppressive Agents
• Cyclophosphamide
• Mycophenolic Acid
• Azathioprine

Topics

• Adrenal Cortex Hormones (therapeutic use)
• Anti-Inflammatory Agents (administration & dosage, therapeutic use)
• Azathioprine (therapeutic use)
• Biopsy (methods)
• Cyclophosphamide (therapeutic use)
• Diagnosis, Differential
• Drug Administration Schedule
• Drug Therapy, Combination
• Humans
• Idiopathic Interstitial Pneumonias (diagnosis, diagnostic imaging, drug therapy, pathology)
• Idiopathic Pulmonary Fibrosis (diagnosis)
• Immunosuppressive Agents (administration & dosage, therapeutic use)
• Lung (pathology)
• Mycophenolic Acid (analogs & derivatives, therapeutic use)
• Tomography, X-Ray Computed
• Treatment Outcome